Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure-Based Function and Regulation of NCX Variants: Updates and Challenges. | Int J Mol Sci | 2022 | 36613523 | PubTator, text mining | PubMed |
| Clinically relevant fusion oncogenes: detection and practical implications. | Ther Adv Med Oncol | 2022 | 36601633 | PubTator, text mining | PubMed |
| Peripartum Management of Congenital Fiber Type Disproportion Myopathy With Severe Restrictive Lung Disease. | Cureus | 2022 | 36600820 | PubTator, text mining | PubMed |
| A narrative review for platelets and their RNAs in cancers: New concepts and clinical perspectives. | Medicine (Baltimore) | 2022 | 36596034 | PubTator, text mining | PubMed |
| Detection of ROS1 gene fusions using next-generation sequencing for patients with malignancy in China. | Front Cell Dev Biol | 2022 | 36589752 | PubTator, text mining | PubMed |
| Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas. | South Asian J Cancer | 2022 | 36588618 | PubTator, text mining | PubMed |
| Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features. | Diagn Pathol | 2022 | 36585729 | PubTator, text mining | PubMed |
| NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series. | J Pers Med | 2022 | 36579526 | PubTator, text mining | PubMed |
| Structures of adenosine receptor A2BR bound to endogenous and synthetic agonists. | Cell Discov | 2022 | 36575181 | PubTator, text mining | PubMed |
| Understanding the Dynamics of the Structural States of Cannabinoid Receptors and the Role of Different Modulators. | Life (Basel) | 2022 | 36556502 | PubTator, text mining | PubMed |
| Screening and Analysis of Serum Protein Biomarkers Infected by Coronavirus Disease 2019 (COVID-19). | Trop Med Infect Dis | 2022 | 36548652 | PubTator, text mining | PubMed |
| Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer. | Ther Adv Med Oncol | 2022 | 36544540 | PubTator, text mining | PubMed |
| Insights into divalent cation regulation and G13-coupling of orphan receptor GPR35. | Cell Discov | 2022 | 36543774 | PubTator, text mining | PubMed |
| Genome-wide association study and genomic prediction for intramuscular fat content in Suhuai pigs using imputed whole-genome sequencing data. | Evol Appl | 2022 | 36540634 | PubTator, text mining | PubMed |
| Structural investigation of human cystine/glutamate antiporter system xc - (Sxc -) using homology modeling and molecular dynamics. | Front Mol Biosci | 2022 | 36533083 | PubTator, text mining | PubMed |
| NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy. | Acta Neuropathol Commun | 2022 | 36528760 | PubTator, text mining | PubMed |
| The roles and mechanisms of the lncRNA-miRNA axis in the progression of esophageal cancer: a narrative review. | J Thorac Dis | 2022 | 36524088 | PubTator, text mining | PubMed |
| CryoEM structures of anion exchanger 1 capture multiple states of inward- and outward-facing conformations. | Commun Biol | 2022 | 36517642 | PubTator, text mining | PubMed |
| Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer. | Mol Biomed | 2022 | 36508072 | PubTator, text mining | PubMed |
| Proton-coupled monocarboxylate transporters in cancer: From metabolic crosstalk, immunosuppression and anti-apoptosis to clinical applications. | Front Cell Dev Biol | 2022 | 36506099 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=27